Latest news
Relapsed/Refractory Multiple Myeloma: Applying Real-World Evidence to CAR T-Cell Therapy - onclive.comonclive.com · Tue, 11 Aug 2026 08:03:45 GMTEvaluating the Future of CAR-T Studies in Systemic Sclerosis - EMJEMJ · Tue, 11 Aug 2026 00:10:31 GMTCAR-T Therapy Access: Unmet Needs and Geographic Gaps - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Mon, 10 Aug 2026 16:29:44 GMTAdding Ibrutinib to Liso-Cel Drives Deep Remissions in R/R CLL/SLL - Targeted OncologyTargeted Oncology · Mon, 10 Aug 2026 16:07:16 GMTReimbursement and Geography as Barriers to CAR-T Access - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Mon, 10 Aug 2026 13:15:03 GMTDecade-long persistence of CD19 CAR T cells in B cell lymphomas - nature.comnature.com · Mon, 10 Aug 2026 09:28:00 GMTDoes Patient Selection Inflate CAR T Outcomes in Multiple Myeloma? - CancerNetworkCancerNetwork · Sun, 09 Aug 2026 16:10:02 GMTLow Dose CAR T Therapy Achieved High Remission Rates - EMJEMJ · Sun, 09 Aug 2026 15:03:11 GMT